Some DBV Technologies (EPA:DBV) Shareholders Have Taken A Painful 83% Share Price Drop

DBV Technologies S.A. (EPA:DBV) shareholders will doubtless be very grateful to see the share price up 43% in the last month. But only the myopic could ignore the astounding decline over three years. The share price has sunk like a leaky ship, down 83% in that time. So it's about time shareholders saw some gains. But the more important question is whether the underlying business can justify a higher price still.

We really hope anyone holding through that price crash has a diversified portfolio. Even when you lose money, you don't have to lose the lesson.

Check out our latest analysis for DBV Technologies

DBV Technologies wasn't profitable in the last twelve months, it is unlikely we'll see a strong correlation between its share price and its earnings per share (EPS). Arguably revenue is our next best option. Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. That's because fast revenue growth can be easily extrapolated to forecast profits, often of considerable size.

In the last three years, DBV Technologies saw its revenue grow by 9.8% per year, compound. That's a fairly respectable growth rate. So it's hard to believe the share price decline of 44% per year is due to the revenue. It could be that the losses were much larger than expected. If you buy into companies that lose money then you always risk losing money yourself. Just don't lose the lesson.

The image below shows how earnings and revenue have tracked over time (if you click on the image you can see greater detail).

ENXTPA:DBV Income Statement May 12th 2020
ENXTPA:DBV Income Statement May 12th 2020

If you are thinking of buying or selling DBV Technologies stock, you should check out this FREE detailed report on its balance sheet.

Advertisement

A Different Perspective

We regret to report that DBV Technologies shareholders are down 32% for the year. Unfortunately, that's worse than the broader market decline of 11%. However, it could simply be that the share price has been impacted by broader market jitters. It might be worth keeping an eye on the fundamentals, in case there's a good opportunity. Unfortunately, last year's performance may indicate unresolved challenges, given that it was worse than the annualised loss of 24% over the last half decade. We realise that Baron Rothschild has said investors should "buy when there is blood on the streets", but we caution that investors should first be sure they are buying a high quality business. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. For example, we've discovered 2 warning signs for DBV Technologies (1 is a bit concerning!) that you should be aware of before investing here.

If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: insiders have been buying them).

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on FR exchanges.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.

About ENXTPA:DBV

DBV Technologies

A clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France.

High growth potential with excellent balance sheet.

Advertisement

Weekly Picks

DA
davidlsander
NAUF.F logo
davidlsander on Nevgold ·

The U.S. Government Is Desperate for This Metal. This Tiny Miner Has It -- Its Closest Peer Is Already Worth Double.

Fair Value:US$2.1943.7% undervalued
48 users have followed this narrative
0 users have commented on this narrative
5 users have liked this narrative
WE
WealthAP
NOVO B logo
WealthAP on Novo Nordisk ·

Novo Nordisk (NVO): Is the "Easy Growth" Story Over?

Fair Value:DKK 407.7720.5% undervalued
26 users have followed this narrative
0 users have commented on this narrative
2 users have liked this narrative
VA
ValueInvestingSubstack
ZTS logo
ValueInvestingSubstack on Zoetis ·

Zoetis down -50% over the past year

Fair Value:US$92.9218.9% undervalued
8 users have followed this narrative
0 users have commented on this narrative
4 users have liked this narrative
CE
CentryResearch
LEU logo
CentryResearch on Centrus Energy ·

Centrus Energy: The Next Nuclear Bottleneck Isn't Reactors. It's Fuel.

Fair Value:US$1909.9% undervalued
1 users have followed this narrative
0 users have commented on this narrative
2 users have liked this narrative

Updated Narratives

DA
SHL logo
danmad on Sonic Healthcare ·

Sonic Healthcare is poised for large upside as margins recover

Fair Value:AU$2721.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
CE
CentryResearch
DKNG logo
CentryResearch on DraftKings ·

DraftKings: Priced for Pessimism, But Are the Risks Fully Priced In?

Fair Value:US$20.9713.7% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
TH
TheTurntTomato
OPRA logo
TheTurntTomato on Opera ·

The Market Is Valuing a Browser While Opera Is Building an AI-Powered Internet Platform

Fair Value:US$26.2925.3% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

IN
Investingwilly
MA logo
Investingwilly on Mastercard ·

Mastercard: The Best Dividend Stock You're Ignoring

Fair Value:US$75028.2% undervalued
98 users have followed this narrative
1 users have commented on this narrative
9 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6514.1% undervalued
67 users have followed this narrative
2 users have commented on this narrative
10 users have liked this narrative
BL
BlackGoat
CBRS logo
BlackGoat on Cerebras Systems ·

The Wafer Giant Threatening NVIDIA's GPU Hegemony

Fair Value:US$415.5449.8% undervalued
64 users have followed this narrative
3 users have commented on this narrative
11 users have liked this narrative